M2 Cobalt Confirms Two Drill-Ready Targets and Numerous High Priority Targets at Its Kilembe Area Properties
HashChain Technology Receives Shipment of 6,000 Cryptocurrency Mining Rigs. First 1,000 Rigs Have Been Deployed
CROP Partners on San Bernardino and West Hollywood, California Dispensary Applications: Emerald Heights
First Volunteers Dosed in Phase I Clinical Trial of PBT434, Prana’s Lead Therapy for Parkinsonian Diseases
Theratechnologies Submits Novel Single-Vial Formulation of EGRIFTA (Tesamorelin for Injection) for FDA Approval
Infinite Lithium Discovers Four New Lithium Pegmatites at the Jackpot Project, Ontario – Lithium Mineralization Much More Extensive than Originally Anticipated
MGX Minerals Announces Completion of Initial Four Holes at Silicon Property; Solar Silicon Metallurgy Underway
LG Chem and Nemaska Lithium Announce Signature of An Initial 5-Year Supply Agreement for Lithium Hydroxide
HashChain Technology Announces Intent to Spin off NODE40, its Blockchain Technology Business into a Stand-Alone Public Company
American Manganese Initiates New IP Development and Pilot Plant Testing to Advance Cathode Recycling Technology
Antibe Therapeutics Releases Secondary Endpoint Data from Recent Phase 2B Gastrointestinal Safety Study for Lead Drug, ATB-346
Sorrento Acquires the Sofusa Lymphatic Delivery Platform for Immune-Oncology (I-O) Antibody Therapeutics
Anavex Life Sciences Receives Approval To Initiate Phase 2b/3 Clinical Trial of ANAVEX 2-73 for the Treatment of Early Alzheimer’s Disease